You are here

Combined oestrogen-progestin contraception

Document

Deep vein thrombosis - Combined oestrogen-progestin contraception Factor

Last reviewed for CCPS 22 December 2008.

Investigative Documents

Claimant Report - Combined Oestrogen-Progestin Contraception - Deep Vein Thrombosis [CR9305]

Preliminary questions [21247]

40433

there is some evidence that combined oestrogen-progestin contraception may be a factor in the development of the condition under consideration.

1169the veteran is a woman.

21390

the veteran used combined oestrogen-progestin contraception for a period of at least three weeks within the 90 days before the clinical onset of the condition under consideration.

21391the veteran has established the causal connection between combined oestrogen-progestin contraception and VEA service for the clinical onset of deep vein thrombosis.

21392the veteran has established the causal connection between combined oestrogen-progestin contraception and operational service for the clinical onset of deep vein thrombosis.

or

21393the veteran has established the causal connection between combined oestrogen-progestin contraception and eligible service for the clinical onset of deep vein thrombosis.

Clinical onset and operational service [21392]

35792

the veteran's use of combined oestrogen-progestin contraception for a period of at least three weeks within the 90 days before the clinical onset of the condition under consideration was due to operational service.

Clinical onset and eligible service [21393]

35793

the veteran's use of combined oestrogen-progestin contraception for a period of at least three weeks within the 90 days before the clinical onset of the condition under consideration was due to eligible service.